TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,278,619 | +4.7% | 211,934 | +6.3% | 0.00% | +50.0% |
| Q2 2023 | $3,130,799 | +10.9% | 199,287 | +15.4% | 0.00% | 0.0% |
| Q1 2023 | $2,824,201 | +17.7% | 172,734 | +12.3% | 0.00% | 0.0% |
| Q4 2022 | $2,399,592 | -88.9% | 153,820 | -90.7% | 0.00% | -89.5% |
| Q3 2022 | $21,527,000 | +1397.0% | 1,659,743 | +1520.4% | 0.02% | +1800.0% |
| Q2 2022 | $1,438,000 | +41.8% | 102,425 | +44.7% | 0.00% | 0.0% |
| Q1 2022 | $1,014,000 | +20.3% | 70,780 | +14.5% | 0.00% | 0.0% |
| Q4 2021 | $843,000 | -9.5% | 61,839 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $932,000 | -2.7% | 56,894 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $958,000 | +84.2% | 56,894 | +99.9% | 0.00% | – |
| Q1 2021 | $520,000 | +23.8% | 28,458 | +23.3% | 0.00% | – |
| Q4 2020 | $420,000 | +25.7% | 23,078 | +23.1% | 0.00% | – |
| Q3 2020 | $334,000 | +2.1% | 18,744 | +2.6% | 0.00% | – |
| Q2 2020 | $327,000 | +66.8% | 18,262 | +41.3% | 0.00% | – |
| Q1 2020 | $196,000 | – | 12,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |